You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Research using the T2Plex instrument has detected a new conformation of red blood cells indicating a tight clot, which could be used as a biomarker.
Hologic's CEO said in December that the blood screening business was a drag on the company's growth.
The launch of the cobas m 511 system marks Roche's entry into the hematology space.
Accriva said that its product portfolio will strengthen Instrumentation Laboratory's position in point-of-care testing.
The agency issued 510k) clearance to several of Siemens' products for use on the Sysmex CS2100i instrument.
Modeled on a children's toy, the device can separate plasma from whole blood in less than two minutes and costs $.20 to make.
The firm expects that the CE-marked i-STAT Alinity will eventually replace the existing i-STAT instrument, which is in one of every three hospitals.
Under the agreement, researchers can use Foundation Medicine's assays to select patients eligible for Sarah Cannon Research Institute's clinical studies.
The lead investigators said that Foundation Medicine's NGS test will enable the beginning of targeted treatment within seven days of diagnosis.
The Swiss firm also reported an 8 percent year-over-year increase in diagnostics sales in the second quarter at constant exchange rates.
Abbott's MDx sales were driven by continued strong growth in its infectious disease testing business but were partly offset by the planned scale down of its genetics business.
The deal gives Bayer access to the T2 Magnetic Resonance technology for drug discovery and biomarker research in certain hemostasis programs.
Abbott reported Diagnostics sales of $1.12 billion, up 2 percent on a reported basis and 7 percent excluding foreign currency effects.
The companies will work together to pursue US Food and Drug Administration clearance for a workflow combining Siemens' sample prep module and Thermo's qPCR instrument.
The company will use the funding to prepare for the 2017 launch of its DiagCore integrated molecular and immunoassay near-patient testing platform.